Assignee
AMBRX INC
US·69 granted patents·45 pending applications·1,358 citations·filing 2004–2024
Top patents by PatentIndex Score
114 records- 0199US7820766B2Branched acetylene-containing poly(alkylene oxides, oxyethylated polyols or olefinic alcohols)AMBRX INC·Filed 2010·Granted Oct 26, 2010·26 cites·2 claims
- 0299US7696312B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Apr 13, 2010·63 cites·17 claims
- 0399US7638491B2Therapies using non-natural amino acids and polypeptidesAMBRX INC·Filed 2005·Granted Dec 29, 2009·40 cites·6 claims
- 0499US7385028B2Derivatization of non-natural amino acids and polypeptidesAMBRX INC·Filed 2005·Granted Jun 10, 2008·91 cites·20 claims
- 0599US7332571B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2005·Granted Feb 19, 2008·101 cites·6 claims
- 0698US8053560B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Nov 8, 2011·40 cites·5 claims
- 0798US8012931B2Modified FGF-21 polypeptides and their usesAMBRX INC·Filed 2008·Granted Sep 6, 2011·76 cites·52 claims
- 0898US8008456B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Aug 30, 2011·28 cites·8 claims
- 0998US7919591B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Apr 5, 2011·41 cites·1 claims
- 1098US7737226B2Acetylene group-containing poly(alkylene oxide, oxyethylated polyol or olefinic alcohol)AMBRX INC·Filed 2007·Granted Jun 15, 2010·26 cites·20 claims
- 1197US8367612B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2009·Granted Feb 5, 2013·14 cites·6 claims
- 1297US8048988B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Nov 1, 2011·28 cites·10 claims
- 1397US8008428B2Azide- or acetylene-terminated poly(alkylene oxide, oxyethylated polyol or olefinic Alcohol)AMBRX INC·Filed 2007·Granted Aug 30, 2011·21 cites·8 claims
- 1497US7928163B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Apr 19, 2011·31 cites·12 claims
- 1597US7883866B2Compositions of aminoacyl-tRNA synthetase and uses thereofAMBRX INC·Filed 2010·Granted Feb 8, 2011·29 cites·14 claims
- 1697US7829310B2Compositions of aminoacyl-tRNA synthetase and uses thereofAMBRX INC·Filed 2010·Granted Nov 9, 2010·29 cites·19 claims
- 1797US7632924B2Antigen-binding polypeptides and their usesAMBRX INC·Filed 2005·Granted Dec 15, 2009·79 cites·8 claims
- 1897US7230068B2Polymer derivativesAMBRX INC·Filed 2004·Granted Jun 12, 2007·45 cites·51 claims
- 1996US10253083B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted Apr 9, 2019·11 cites·20 claims
- 2096US8383365B2Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivativesAMBRX INC·Filed 2011·Granted Feb 26, 2013·48 cites·60 claims
- 2196US8022186B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Sep 20, 2011·20 cites·5 claims
- 2296US7947473B2Methods for expression and purification of pegylated recombinant human growth hormone containing a non-naturally encoded keto amino acidAMBRX INC·Filed 2008·Granted May 24, 2011·25 cites·4 claims
- 2396US7888533B2Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptidesAMBRX INC·Filed 2007·Granted Feb 15, 2011·35 cites·10 claims
- 2496US7858344B2Compositions of aminoacyl-tRNA synthetase and uses thereofAMBRX INC·Filed 2010·Granted Dec 28, 2010·20 cites·19 claims
- 2596US7846689B2Compositions of aminoacyl-tRNA synthetase and uses thereofAMBRX INC·Filed 2010·Granted Dec 7, 2010·22 cites·14 claims
- 2696US7838265B2Compositions of aminoacyl-tRNA synthetase and uses thereofAMBRX INC·Filed 2010·Granted Nov 23, 2010·26 cites·14 claims
- 2796US7638299B2Biosynthetic polypeptides utilizing non-naturally encoded amino acidsAMBRX INC·Filed 2005·Granted Dec 29, 2009·63 cites·11 claims
- 2895US10751391B2Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acidAMBRX INC·Filed 2019·Granted Aug 25, 2020·6 cites·24 claims
- 2995US7816320B2Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35AMBRX INC·Filed 2005·Granted Oct 19, 2010·40 cites·18 claims
- 3095US7736872B2Compositions of aminoacyl-TRNA synthetase and uses thereofAMBRX INC·Filed 2005·Granted Jun 15, 2010·31 cites·20 claims
- 3195US7468458B2Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptidesAMBRX INC·Filed 2007·Granted Dec 23, 2008·24 cites·26 claims
- 3294US10702588B2Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chainAMBRX INC·Filed 2018·Granted Jul 7, 2020·7 cites·20 claims
- 3394US9975936B2Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2016·Granted May 22, 2018·12 cites·20 claims
- 3494US9567386B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2013·Granted Feb 14, 2017·14 cites·12 claims
- 3594US9079971B2Modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2013·Granted Jul 14, 2015·19 cites·39 claims
- 3694US7939496B2Modified human growth horomone polypeptides and their usesAMBRX INC·Filed 2005·Granted May 10, 2011·25 cites·4 claims
- 3793US9517273B2Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2015·Granted Dec 13, 2016·15 cites·20 claims
- 3893US7959926B2Methods for expression and purification of recombinant human growth hormone mutantsAMBRX INC·Filed 2007·Granted Jun 14, 2011·24 cites·4 claims
- 3992US9962450B2Method of treating heart failure with modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted May 8, 2018·9 cites·21 claims
- 4092US7632823B2Compositions of tRNA and uses thereofAMBRX INC·Filed 2005·Granted Dec 15, 2009·19 cites·43 claims
- 4191US9452222B2Nucleic acids encoding modified relaxin polypeptidesAMBRX INC·Filed 2014·Granted Sep 27, 2016·14 cites·19 claims
- 4288US9586988B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2013·Granted Mar 7, 2017·4 cites·4 claims
- 4387US2024189392A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2023·Application pending·0 cites
- 4486US10961291B2Modified FGF-21 polypeptides and their usesAMBRX INC·Filed 2019·Granted Mar 30, 2021·1 cites·26 claims
- 4586US9637441B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2014·Granted May 2, 2017·1 cites·24 claims
- 4684US10954270B2Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivativesAMBRX INC·Filed 2017·Granted Mar 23, 2021·2 cites·13 claims
- 4784US10377805B2Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their usesAMBRX INC·Filed 2018·Granted Aug 13, 2019·2 cites·21 claims
- 4882US9644014B2Modified animal erythropoietin polypeptides and their usesAMBRX INC·Filed 2015·Granted May 9, 2017·3 cites·12 claims
- 4981US11786578B2Modified relaxin polypeptides and their usesAMBRX INC·Filed 2022·Granted Oct 17, 2023·0 cites·19 claims
- 5081US2023028168A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 114 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →